Document Detail


Thalidomide: current therapeutic uses and management of its toxicities.
MedLine Citation:
PMID:  12696209     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thalidomide currently is used to treat relapsed and refractory multiple myeloma. The drug also is being actively investigated in patients newly diagnosed with multiple myeloma. The therapeutic applications of thalidomide are expected to grow as clinical trials document its activity in treating other neoplastic disorders and diseases. Healthcare providers need to be well informed of its toxicities and able to identify their signs and symptoms immediately. They must have adequate knowledge about thalidomide administration and provide comprehensive patient education regarding thalidomide and its toxicities to ensure patient safety and compliance.
Authors:
Joseph D Tariman
Related Documents :
19147779 - Clinical and immunohistochemical features associated with a response to bortezomib in p...
12218389 - Mortality of hiv-1, hiv-2 and hiv-1/hiv-2 dually infected patients in a clinic-based co...
12803129 - Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.
15844689 - Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts.
12461419 - Increased risk of lipoatrophy under stavudine in hiv-1-infected patients: results of a ...
16630379 - Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring durin...
23862029 - Idiopathic granulomatous mastitis: diagnostic strategy and therapeutic implications in ...
24330079 - Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a...
8854299 - A clinical and neuropsychological comparison of delusional disorder and schizophrenia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical journal of oncology nursing     Volume:  7     ISSN:  1092-1095     ISO Abbreviation:  Clin J Oncol Nurs     Publication Date:    2003 Mar-Apr
Date Detail:
Created Date:  2003-04-16     Completed Date:  2003-05-08     Revised Date:  2014-03-21    
Medline Journal Info:
Nlm Unique ID:  9705336     Medline TA:  Clin J Oncol Nurs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  143-7     Citation Subset:  N    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology
Angiogenesis Inhibitors / adverse effects*,  therapeutic use
Constipation / chemically induced
Humans
Peripheral Nervous System Diseases / chemically induced
Thalidomide / adverse effects*,  therapeutic use
Venous Thrombosis / chemically induced
Grant Support
ID/Acronym/Agency:
F31 NR011124/NR/NINR NIH HHS
Chemical
Reg. No./Substance:
0/Angiogenesis Inhibitors; 4Z8R6ORS6L/Thalidomide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term study of tiopronin in patients with cystinuria
Next Document:  Leptomeningeal metastases.